ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
登入
立即註冊
Toggle
澳股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
PROTEOMICS INTERNATIONAL LAB
0.365
0.000
成交量:
1.18萬
成交額:
4,366.00
市值:
6,026.75萬
市盈率:
-6.04
高:
0.382
開:
0.365
低:
0.365
收:
0.365
52周最高:
0.860
52周最低:
0.285
股本:
1.65億
流通股本:
1.22億
量比:
0.53
換手率:
0.01%
股息:
- -
股息率:
- -
每股收益(TTM):
-0.060
每股收益(LYR):
-0.060
淨資產收益率:
-73.41%
總資產收益率:
-40.28%
市淨率:
4.58
市盈率(LYR):
-6.04
資料載入中...
總覽
公司
新聞資訊
公告
蛋白質組國際實驗室獲加拿大專利保護,Promarkereso食管腺癌診斷測試再添利器
美股速递
·
01/16
PROTEOMICS INTERNATIONAL LAB獲得美國專利,用於食管腺癌的Promarkereso診斷測試
美股速递
·
2025/12/17
PROTEOMICS INTERNATIONAL LAB顯著改變醫生管理DKD的方式 - 研究發表
美股速递
·
2025/12/16
PROTEOMICS INTERNATIONAL LAB獲得220萬美元研發税收激勵
美股速递
·
2025/11/12
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/PIQ.AU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PIQ.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PIQ.AU\",,,,,undefined,":{"symbol":"PIQ.AU","market":"AU","secType":"STK","nameCN":"PROTEOMICS INTERNATIONAL LAB","latestPrice":0.365,"timestamp":1771889175057,"preClose":0.365,"halted":0,"volume":11843,"delay":0,"changeRate":0,"nameEN":"PROTEOMICS INTERNATIONAL LAB","floatShares":121549097,"shares":165116433,"eps":-0.060439,"marketStatus":"交易中","change":0,"latestTime":"02-24 10:27:48 AEDT","open":0.365,"high":0.382,"low":0.365,"amount":4366,"amplitude":0.046575,"askPrice":0.37,"askSize":1991,"bidPrice":0.36,"bidSize":24756,"shortable":3,"etf":0,"ttmEps":-0.060439,"tradingStatus":2,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1771909200000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.365,"openAndCloseTimeList":[[1771887600000,1771909200000]],"volumeRatio":0.526646,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PIQ.AU\",,,,,undefined,":{"symbol":"PIQ.AU","floatShares":121549097,"roa":"-40.28%","roe":"-73.41%","lyrEps":-0.060439,"volumeRatio":0.526646,"shares":165116433,"dividePrice":0,"high":0.382,"amplitude":0.046575,"preClose":0.365,"low":0.365,"week52Low":0.285,"pbRate":"4.58","psRate":"18.19","week52High":0.86,"institutionHeld":0,"latestPrice":0.365,"committee":0.851123,"eps":-0.060439,"divideRate":0,"volume":11843,"delay":0,"ttmEps":-0.060439,"open":0.365,"prevYearClose":0.655,"prevWeekClose":0.375,"prevMonthClose":0.47,"prevQuarterClose":0.655,"fiveDayClose":0.395,"twentyDayClose":0.65,"sixtyDayClose":0.39},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PIQ.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PIQ.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PIQ.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1163495272","title":"蛋白質組國際實驗室獲加拿大專利保護,Promarkereso食管腺癌診斷測試再添利器","url":"https://stock-news.laohu8.com/highlight/detail?id=1163495272","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163495272?lang=zh_tw&edition=fundamental","pubTime":"2026-01-16 05:24","pubTimestamp":1768512278,"startTime":"0","endTime":"0","summary":"蛋白质组国际实验室宣布,其创新产品Promarkereso食管腺癌诊断测试成功获得加拿大专利授权。这一重要里程碑标志着该诊断技术在知识产权保护方面取得实质性进展,为后续商业化应用奠定坚实基础。\n专利的获取不仅提升了Promarkereso诊断测试的市场竞争力,更彰显了公司在生物医学检测领域的研发实力。食管腺癌作为消化道常见恶性肿瘤,早期诊断对提升患者生存率具有关键意义,此项专利技术有望为临床诊断提供更精准高效的解决方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7048","PIQ.AU"],"gpt_icon":0},{"id":"1166134718","title":"PROTEOMICS INTERNATIONAL LAB獲得美國專利,用於食管腺癌的Promarkereso診斷測試","url":"https://stock-news.laohu8.com/highlight/detail?id=1166134718","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166134718?lang=zh_tw&edition=fundamental","pubTime":"2025-12-17 05:34","pubTimestamp":1765920868,"startTime":"0","endTime":"0","summary":"PROTEOMICS INTERNATIONAL LAB获得了美国专利,用于食管腺癌的Promarkereso诊断测试。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","PIQ.AU","BK7508"],"gpt_icon":0},{"id":"1152204478","title":"PROTEOMICS INTERNATIONAL LAB顯著改變醫生管理DKD的方式 - 研究發表","url":"https://stock-news.laohu8.com/highlight/detail?id=1152204478","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152204478?lang=zh_tw&edition=fundamental","pubTime":"2025-12-16 05:47","pubTimestamp":1765835228,"startTime":"0","endTime":"0","summary":"PROTEOMICS INTERNATIONAL LAB显著改变医生管理DKD的方式 - 研究发表","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","PIQ.AU","BK7048"],"gpt_icon":0},{"id":"1109160475","title":"PROTEOMICS INTERNATIONAL LAB獲得220萬美元研發税收激勵","url":"https://stock-news.laohu8.com/highlight/detail?id=1109160475","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109160475?lang=zh_tw&edition=fundamental","pubTime":"2025-11-12 06:05","pubTimestamp":1762898708,"startTime":"0","endTime":"0","summary":"PROTEOMICS INTERNATIONAL LAB获得220万美元研发税收激励","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7048","PIQ.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}]}}